Effects of CSL324 in the Lung After Segmental Challenge
Clinical trial NCT05653713 · COMPLETED
Trial details
- NCT number
- NCT05653713
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2023-07-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.